0001209191-23-057640.txt : 20231206
0001209191-23-057640.hdr.sgml : 20231206
20231206170547
ACCESSION NUMBER: 0001209191-23-057640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231204
FILED AS OF DATE: 20231206
DATE AS OF CHANGE: 20231206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN JEREMY M
CENTRAL INDEX KEY: 0001256153
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 231470404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 441 NINTH AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-04
0
0001636651
Ovid Therapeutics Inc.
OVID
0001256153
LEVIN JEREMY M
C/O OVID THERAPEUTICS INC.
441 NINTH AVENUE
NEW YORK
NY
10001
1
1
0
0
CEO
0
Common Stock
2023-12-04
4
G
0
573275
0.00
D
4171742
D
Common Stock
2023-12-04
4
G
0
573275
0.00
D
3598467
D
Common Stock
35461
I
See Footnote
The reporting executive has transferred shares to a family trust for the benefit of his children as part of generational estate planning. The
reporting executive has made these transfers for no consideration. The reporting executive does not serve as the trustee of the family trusts, nor
does he maintain investment control over, or have a pecuniary interest in, the shares.
This direct ownership total corrects an inadvertent administrative error in the number of shares of common stock that were reported as directly held on the Form 4 filed by the reporting executive on September 1, 2020. Before the transactions reported herein, the reporting executive held 4,745,017 shares of common stock directly
The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The reporting executive's spouse is the manager of Divo. The
reporting executive disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial
ownership of such shares for the purposes of Section 16 or for any other purpose.
/s/ Danielle Mann for Jeremy Levin PoA
2023-12-06